<--- Back to Details
First PageDocument Content
Medicine / Medicinal radiochemistry / Clinical medicine / Medical imaging / Radiopharmaceuticals / Neuroimaging / Medical physics / Radiobiology / Positron emission tomography / Single-photon emission computed tomography / Nuclear medicine / Radioactive tracer
Date: 2016-08-17 16:07:13
Medicine
Medicinal radiochemistry
Clinical medicine
Medical imaging
Radiopharmaceuticals
Neuroimaging
Medical physics
Radiobiology
Positron emission tomography
Single-photon emission computed tomography
Nuclear medicine
Radioactive tracer

THE U~VERSITY OF NEW MEXICO COLLEGE OF PHARMACY ALBUQUERQUE, NEW MEXICO

Add to Reading List

Source URL: pharmacyce.unm.edu

Download Document from Source Website

File Size: 2,17 MB

Share Document on Facebook

Similar Documents

What Is PET? Positron Emission Tomography (PET) is a non-invasive form of medical imaging approved by Medicare for diagnosis and management of several forms of cancer including: 	 Lung Cancer

What Is PET? Positron Emission Tomography (PET) is a non-invasive form of medical imaging approved by Medicare for diagnosis and management of several forms of cancer including: Lung Cancer

DocID: 1uv0l - View Document

Determining the diagnostic kinetics of viral encephalitis using positron emission tomography (PET) in Münster Nicholas King, Discipline of Pathology, Bosch Institute, School of Medical Sciences, Sydney Medical School, U

Determining the diagnostic kinetics of viral encephalitis using positron emission tomography (PET) in Münster Nicholas King, Discipline of Pathology, Bosch Institute, School of Medical Sciences, Sydney Medical School, U

DocID: 1rQ7R - View Document

Histopathologic Features that Influence the Detection of Occult Lymph Node Metastasis Using PET/CT Imaging with Anti-PSMA Df-IAB2M in Newly Diagnosed High Risk Prostate Cancer Patients. 89Zr-  Bernard M. Gburek1, Anthony

Histopathologic Features that Influence the Detection of Occult Lymph Node Metastasis Using PET/CT Imaging with Anti-PSMA Df-IAB2M in Newly Diagnosed High Risk Prostate Cancer Patients. 89Zr- Bernard M. Gburek1, Anthony

DocID: 1rqYg - View Document

THE U~VERSITY OF NEW MEXICO COLLEGE OF PHARMACY ALBUQUERQUE, NEW MEXICO

THE U~VERSITY OF NEW MEXICO COLLEGE OF PHARMACY ALBUQUERQUE, NEW MEXICO

DocID: 1riLo - View Document

Microsoft Word - 25-32_FINAL_SN0302.doc

Microsoft Word - 25-32_FINAL_SN0302.doc

DocID: 1rbdW - View Document